Related references
Note: Only part of the references are listed.Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels
M. G. Castagna et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Review on the occasion of a decade of recombinant human TSH: Prospects and novel uses
Leonidas H. Duntas et al.
THYROID (2008)
Is adjuvant therapy useful in patients with papillary carcinoma smaller than 2 cm?
Pedro W. S. Rosario et al.
THYROID (2007)
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer
Tania Pilli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients
M. Schlumberger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Thyroid nodules and differentiated thyroid cancer:: Brazilian consensus
Ana Luiza Maia et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)
Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH: Why, how and when
D. Barbaro et al.
EJSO (2007)
Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal
I. Borget et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer
Martin Schlumberger et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine
Richard J. Robbins et al.
THYROID (2006)
The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer
K. Kulkarni et al.
THYROID (2006)
Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective
P. Mernagh et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
PR Schroeder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
BR Smith et al.
THYROID (2006)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: A one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration
M Luster et al.
THYROID (2005)
Long-term risk of second malignant neoplasms after neuroblastoma in childhood:: Role of treatment
C Rubino et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma - Response
EL Mazzaferri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Ablation of thyroid residues with 30 mCi 131I:: A comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
EL Mazzaferri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin
RJ Robbins et al.
THYROID (2001)
Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma
M Luster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
